AK Medical (HKG:1789) said it intends to conduct on-market share repurchases of up to HK$150 million under its general mandate, according to a Monday Hong Kong bourse filing.
The mandate allows the company to buy back up to about 112.3 million shares, or 10% of its issued share capital, as at the June 18, 2025, annual general meeting.
The repurchases will be funded by internal resources, and all bought-back shares will be cancelled, the company said.